Skip to Main Content

ILD Center Media

ILD Center News

The Chemotherapy+ Foundation Honors YCC Deputy Director

Dr. Roy S. Herbst, MD, PhD received the 2024 Ezra Greenspan Award from The Chemotherapy+ Foundation at a gala in New York Nov. 19, 2024. He is a deputy director of the Yale Cancer Center and Chief of Hematology/Medical Oncology, YCC and Smilow Cancer Hospital; Assistant Dean for Translational Research, Yale School of Medicine; Program Director, Master of Health Science—Clinical Investigation Track (MHS-CI)

Read more
  • Health Equity Summit Celebrates Achievements, Plans Future Solutions

    Early in the COVID-19 pandemic, racial outcome disparities emerged. In the first year, for example, Black and Hispanic patients were far likelier to die than white patients were. Yet a bright spot occurred at Yale. Not only was the mortality rate throughout Yale New Haven Health in the pandemic’s first two years lower than the national average, but also no race-based survival differences occurred among discharged patients.

    Read more
  • How Diet Interacts with the Gut

    The 14th Iva Dostanic lectureship took place on Thursday, June 20, 2024 with Lisa Korn, MD, PhD, instructor of medicine (rheumatology, allergy and immunology), presenting her research findings on diet-immune interactions.

    Read more
  • Pulmonary Learning Spans from Uganda to U.S.

    Yale School of Medicine (YSM) and the Makerere University College of Health Sciences in Uganda have collaborated since 2006 to enhance medical education and research for improved clinical care, under the umbrella of the MUYU collaboration. Over the years, this collaboration has fostered a bidirectional exchange of medical personnel between the two institutions, and has been based in the Office of Global Health in Yale’s Department of Internal Medicine and the MUYU Office at Makerere University College of Health Sciences .

    Read more
  • Unique Immune Profile Identified in Fibrotic Hypersensitivity Pneumonitis

    Fibrotic hypersensitivity pneumonitis is a chronic and progressive interstitial lung disease, caused by an immune response to inhaled foreign antigens or allergens. Researchers from Yale’s Section of Pulmonary, Critical Care and Sleep Medicine have used single-cell sequencing technology to provide the first high-resolution atlas of this disease, revealing a previously unrecognized immune signature. Their findings were recently published in the American Journal of Respiratory and Critical Care Medicine.

    Read more
  • New Endowment To Support Innovation in Rheumatology Care and Research

    Yale School of Medicine's Department of Internal Medicine is pleased to announce the creation of the Endowed Catalyst Fund in Rheumatology, Allergy and Immunology. The fund will be used to support innovation in research and clinical care in the Department of Internal Medicine Section of Rheumatology, Allergy and Immunology.

    Read more
  • Single-Cell Profiling Reveals Insights About Immunity in Idiopathic Pulmonary Fibrosis

    In a new study, published in the American Journal of Respiratory and Critical Care Medicine, researchers used single-cell RNA sequencing to measure the gene expressions of individual peripheral blood mononuclear cells in patients with progressive IPF, patients with stable IPF, and lung-disease-free patients. Previously, the researchers had studied bulk samples of these cells but not examined them individually and in detail.

    Read more
Get RSS Feed